Related Articles
P53 ALTERATIONS SHOW SIGNIFICANT CORRELATION WITH GENE AMPLIFICATION AND S-PHASE INDEX IN BREAST-CANCER
COEXPRESSION OF C-ERBB2 AND INT-2 ONCOGENES IN INVASIVE BREAST-CANCER
Expression of DNA topoisomerase II‑α: Clinical significance in laryngeal carcinoma
LOSS OF WILD-TYPE P53 AND C-ERBB2 AMPLIFICATION CORRELATES WITH HIGH-GRADE BREAST CARCINOMAS
C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer